Trials / Conditions / Chromosome Abnormality

Chromosome Abnormality

15 registered clinical trials studyying Chromosome Abnormality — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717	Masonic Cancer Center, University of Minnesota	Phase 2
Recruiting	Biocollection in MyeloDysplastic Syndrome (P-MDS) NCT04869683	University Hospital, Brest	N/A
Unknown	Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection NCT05547555	Assisting Nature	—
Unknown	Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection NCT05545995	Assisting Nature	—
Terminated	RCT Study to Validate niPGT-A Clinical Benefit. NCT04000152	Igenomix	N/A
Completed	Embryo Selection by Noninvasive Preimplantation Genetic Test NCT04339166	Peking University Third Hospital	N/A
Enrolling By Invitation	Structural Chromosome Rearrangements and Brain Disorders NCT06072079	Karolinska Institutet	—
Completed	Validation of a NICS Method Using the Culture Medium NCT03879265	Instituto Bernabeu	—
Completed	North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 NCT03548779	University of North Carolina, Chapel Hill	N/A
Completed	Clinical Value of Mosaicism Diagnosis on the Trophectoderm Biopsies NCT03673592	Igenomix	—
Completed	Multi-center Study to Validate niPGT-A NCT03520933	Igenomix	—
Completed	Efficacy of Counseling for Prenatal Screening and Diagnostic Tests on Pregnant Women: Randomised Controlled St NCT03825978	Saglik Bilimleri Universitesi Gulhane Tip Fakultesi	N/A
Completed	Post-operative Lite Run Study NCT03135145	Gillette Children's Specialty Healthcare	N/A
Unknown	Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twin NCT02982356	Shanghai First Maternity and Infant Hospital	N/A
Terminated	Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib NCT00461929	University Health Network, Toronto	Phase 4